ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CMRA Comera Life Sciences Holdings Inc

0.045
0.00 (0.00%)
03 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Comera Life Sciences Holdings Inc NASDAQ:CMRA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.045 0.0451 0.065 0 01:00:00

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

31/05/2022 1:01pm

Edgar (US Regulatory)


 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number 001-39708

 

 

OTR ACQUISITION CORP

(Exact name of registrant as specified in its charter)

 

 

12 Gill Street

Suite 4650

Woburn, Massachusetts

(617) 871-2101 

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Units, each consisting of one share of Class A common stock and one-half of one redeemable Warrant

Class A common stock, par value $0.0001 per share

Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of

$11.50 per share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

  Rule 12g-4(a)(1) x  
  Rule 12g-4(a)(2) ¨  
  Rule 12h 3(b)(1)(i) x  
  Rule 12h-3(b)(1)(ii) ¨  
  Rule 15d-6 ¨  
  Rule 15d-22(b) ¨  

 

Approximate number of holders of record as of the certification or notice date: One (1)*.

 

* Effective May 19, 2022, a subsidiary of Comera Life Sciences Holdings, Inc. merged with and into OTR Acquisition Corp., with OTR Acquisition Corp. surviving such merger and becoming a wholly owned subsidiary of Comera Life Sciences Holdings, Inc.  

 

Pursuant to the requirements of the Securities Exchange Act of 1934, OTR Acquisition Corp. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: May 31, 2022 By: /s/ Jeff Hackman
    Name: /s/ Jeff Hackman
    Title: Chairman & CEO

 

 

 

 

 

1 Year Comera Life Sciences Chart

1 Year Comera Life Sciences Chart

1 Month Comera Life Sciences Chart

1 Month Comera Life Sciences Chart

Your Recent History

Delayed Upgrade Clock